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FIGurE 1 Multimodality imaging in a 48‑year‑old man with hypereosinophilic syndrome and recurrent non‑
ST‑segment elevation myocardial infarction (NSTEMI). Invasive coronary angiography (A) revealed in‑stent thrombosis 
in the first diagonal branch of the left anterior descending coronary artery (arrow). Transthoracic echocardiography (B) 
performed 14 days after NSTEMI showed 2 mobile thrombi pedunculated to an akinetic mid anterior segment. Cardiac 
magnetic resonance confirmed akinesis of the mid anteroseptal and anterior segments and demonstrated myocardial 
edema (C) in the mid anterior segment (arrows) using the STIR sequence. Postcontrast magnetic resonance imaging  
(D) revealed: a) transmural late gadolinium enhancement (LGE) in the mid anterior and anteroseptal segments (white 
arrows) representing myocardial infarction, and b) linear intramural LGE in the mid septal segment, subendocardial LGE 
in the mid septal and mid lateral segments, and subepicardial LGE in the mid lateral segment, representing nonischemic 
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distinguish ischemic from nonischemic myocardi‑
al injuries.4 In our patient, CMR delineated trans‑
mural myocardial infarction in the region sup‑
plied by the first diagonal branch, identified non‑
ischemic myocardial injury in the mid septal and 
lateral segments, and excluded significant endo‑
myocardial fibrosis. TTE is definitely the first‑line 
technique to detect intracardiac thrombi. There‑
fore, to exclude intracardiac thrombus in HES 
complicated by acute myocardial infarction, se‑
quential TTE should be performed, and CMR, as 
a superior technique, might be recommended in 
high‑risk patients.
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A 48‑year‑old man with hypereosinophilic syn‑
drome (HES) of unknown etiology was admitted 
with recurrent non‑ST‑segment elevation myo‑
cardial infarction (NSTEMI) and the cardiac tro‑
ponin I levels of 18.2 mg/l. A month earlier, due 
to the first episode of NSTEMI, the first diagonal 
branch of the left anterior descending coronary 
artery was stented, followed by administration of 
75 mg aspirin and 75 mg clopidogrel. Due to exac‑
erbation of HES (erythrocyte sedimentation rate, 
130 mm/h; C‑reactive protein, 96 mg/l; immu‑
noglobulin E, 3360 U/l; leukocytosis, 27,700/µl; 
peripheral blood eosinophilia, 8642/µl), methyl‑
prednisolone (1 mg/kg) was introduced 2 weeks 
before admission. Two days after admission, coro‑
nary angiography showed in‑stent thrombosis in 
the first diagonal branch, successfully reopened 
during the procedure (FIGurE 1A). Two weeks lat‑
er, transthoracic echocardiography (TTE) showed 
left ventricular systolic (ejection fraction, 45%) 
and diastolic dysfunction (E/A, 0.5; deceleration 
time,  444 ms) as well as 2 mobile thrombi pe‑
dunculated to the akinetic mid anterior segment 
(FIGurE 1B). Cardiac magnetic resonance (CMR) 
confirmed the presence of thrombi as well as myo‑
cardial edema (FIGurE 1C) and transmural late gad‑
olinum enhancement (LGE) in the mid anteri‑
or and anteroseptal wall with the subendocardi‑
al no‑reflow phenomenon (FIGurE 1D). Moreover, 
CMR demonstrated nonischemic LGE lesions: 1) 
intramurally in the mid septal, 2) subendocardi‑
ally in the mid septal and mid lateral, and 3) sub‑
epicardially in the mid lateral segments. Enoxapa‑
rin (2 × 1 mg/kg) and methyloprednisolone (3 dai‑
ly pulses of 1000 mg IV, followed by 1 mg/kg) 
were administered in addition to dual antiplate‑
let therapy (aspirin and clopidogrel). Seven days 
later, TTE showed dissolution of one thrombus 
and a significant reduction in the size of the other 
thrombus. A week later, both thrombi complete‑
ly disappeared.
HES is characterized by marked persistent 
eosinophilia of unknown origin and by eosino‑
phil‑mediated organ damage. Cardiac involve‑
ment, which affects more than 50% of the pa‑
tients with HES, is a major cause of morbidity 
and mortality.1,2 Cardiac damage progresses in 
3 stages. An acute myocardial necrosis is followed 
by thrombus formation and ultimately progress‑
es to endomyocardial fibrosis, resulting in restric‑
tive cardiomiopathy.3 Thromboembolic complica‑
tions are frequent and are associated with poor 
outcomes.3
Our report demonstrates the utility of TTE and 
CMR in HES. CMR, unlike TTE, allows to iden‑
tify heart damage in the first stage of the dis‑
ease. The technique enables to visualize LGE le‑
sions, which may represent inflammation or fibro‑
sis.4 However, the differentiation between inflam‑
mation and fibrosis may be difficult, and our case 
showed that small LGE areas cannot be unequiv‑
ocally attributed to one of these processes. LGE 
pattern, location, transmural distribution, and re‑
lation to myocardial coronary artery supply helps 
